Eydelman Mikhail — SEC Form 4 filings
SEC reporting owner CIK 1918033. 18 Form 4 filings on record with FilingPulse; latest filed 2025-03-07.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2024-02-05 to 2025-03-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 52 legs across 15 filings — 48,836 shares, $4,421,841 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: sale of 3,056 shares @ $114.37 ($349,512) in Vaxcyte, Inc., filed 2024-10-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | SVP, GEN COUNSEL & CORP SEC | 18 | — | 52 legs · 48,836 sh · $4,421,841 | 42 |
Form 4 filings — Eydelman Mikhail
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-03-07 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 5,000 @ $21.41 · Sale (S): 2,621 @ $70.39 · Sale (S): 2,267 @ $71.07 · Sale (S): 112 @ $72.37 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 14,484 @ $0 · Tax withholding (F): 470 @ $73.02 · Tax withholding (F): 616 @ $72.10 · Grant/award (A): 48,357 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 5,000 @ $21.41 · Sale (S): 571 @ $87.77 · Sale (S): 635 @ $89.09 · Sale (S): 1,755 @ $89.95 · Sale (S): 1,784 @ $91.05 · Sale (S): 255 @ $91.71 · +1 more | EDGAR |
| 2025-01-07 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 5,000 @ $21.41 · Sale (S): 954 @ $84.86 · Sale (S): 3,921 @ $85.73 · Sale (S): 125 @ $86.52 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-12-09 | 4 | Vaxcyte, Inc. (PCVX) | Gift (G): 110 @ $0 · Option exercise (M): 5,000 @ $21.41 · Sale (S): 1,435 @ $90.16 · Sale (S): 3,177 @ $91.91 · Sale (S): 388 @ $92.90 · Tax withholding (F): 475 @ $92.06 · +1 more | EDGAR |
| 2024-11-08 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 26,125 (derivative) @ $0 | EDGAR |
| 2024-11-06 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 5,000 @ $21.41 · Sale (S): 788 @ $104.80 · Sale (S): 1,415 @ $105.72 · Sale (S): 1,524 @ $106.82 · Sale (S): 1,273 @ $107.50 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-10-08 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 5,000 @ $21.41 · Sale (S): 476 @ $107.51 · Sale (S): 996 @ $108.69 · Sale (S): 3,147 @ $109.55 · Sale (S): 314 @ $110.50 · Sale (S): 67 @ $111.68 · +1 more | EDGAR |
| 2024-10-03 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 5,500 @ $21.41 · Sale (S): 1,414 @ $113.38 · Sale (S): 3,056 @ $114.37 · Sale (S): 1,030 @ $115.01 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 1,667 @ $21.41 · Sale (S): 4 @ $107.67 · Sale (S): 523 @ $110.45 · Sale (S): 715 @ $111.57 · Sale (S): 122 @ $112.66 · Sale (S): 79 @ $114.96 · +4 more | EDGAR |
| 2024-08-05 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 1,667 @ $21.41 · Sale (S): 1,482 @ $78.80 · Sale (S): 185 @ $79.29 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 1,667 @ $21.41 · Sale (S): 913 @ $75.93 · Sale (S): 754 @ $76.90 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 335 @ $70.97 | EDGAR |
| 2024-06-05 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 1,667 @ $21.41 · Sale (S): 751 @ $71.25 · Sale (S): 656 @ $72.37 · Sale (S): 260 @ $73.64 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 1,667 @ $21.41 · Sale (S): 964 @ $61.30 · Sale (S): 559 @ $61.95 · Sale (S): 144 @ $63.90 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 1,667 @ $21.41 · Sale (S): 1,397 @ $66.59 · Sale (S): 270 @ $67.42 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 10,500 @ $0 · Option exercise (M): 1,667 @ $21.41 · Sale (S): 519 @ $73.03 · Sale (S): 703 @ $73.59 · Sale (S): 445 @ $74.77 · Tax withholding (F): 613 @ $71.55 · +2 more | EDGAR |
| 2024-02-05 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 1,667 @ $21.41 · Sale (S): 212 @ $72.22 · Sale (S): 638 @ $73.17 · Sale (S): 343 @ $74.11 · Sale (S): 474 @ $75.39 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1918033 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →